Anlon Healthcare Limited

As of June 30, 2026, Anlon Healthcare Limited carries a market capitalization of 8.50B, placing it among publicly traded companies globally. Its enterprise value stands at 8.50B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Anlon Healthcare Limited has 531.52M shares outstanding.

As of June 30, 2026, Anlon Healthcare Limited trades at a trailing price-to-earnings ratio of 23.44.

As of June 30, 2026, Anlon Healthcare Limited trades at an EV/EBITDA multiple of 14.92 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.76 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.51 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 8.50B versus a market cap of 8.50B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 19.01M in revenue per employee across its workforce of 119.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Anlon Healthcare Limited recorded 105.98M in income tax expense. That works out to an effective tax rate of 0.72, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 14.81B, leaving 316.29M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Anlon Healthcare Limited's stock has gained approximately 91.55% over the past 52 weeks. The 50-day moving average sits at 22.05, while the 200-day moving average is 15.73.

Over the twelve months ended June 30, 2026, Anlon Healthcare Limited generated 2.26B in revenue and converted that into 316.29M in net income, yielding earnings per share of 31.72. EBITDA reached 569.63M, while operating income came in at 547.99M.

Over the twelve months ended June 30, 2026, Anlon Healthcare Limited posted a gross margin of 35.04, reflecting its pricing power and cost economics. The operating margin of 24.22 and net profit margin of 13.98 provide insight into operational efficiency.

Anlon Healthcare Limited's most recent stock split took place on April 24, 2026 with a 1:10 split ratio.